Fidelity Investments’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.46K | Sell |
688
-441
| -39% | -$3.71K | ﹤0.01% | 4863 |
|
|
2025
Q4 | $9.19K | Sell |
1,129
-271
| -19% | -$3.35K | ﹤0.01% | 4762 |
|
|
2025
Q3 | $17.7K | Sell |
1,400
-55
| -4% | -$523 | ﹤0.01% | 4398 |
|
|
2025
Q2 | $10K | Sell |
1,455
-1,916
| -57% | -$13.9K | ﹤0.01% | 4525 |
|
|
2025
Q1 | $17.9K | Buy |
3,371
+3,219
| +2,118% | +$28.4K | ﹤0.01% | 4265 |
|
|
2024
Q4 | $1.79K | Sell |
152
-9,876
| -98% | -$166K | ﹤0.01% | 4837 |
|
|
2024
Q3 | $207K | Buy |
10,028
+2,486
| +33% | +$127K | ﹤0.01% | 3179 |
|
|
2024
Q2 | $341K | Sell |
7,542
-1,612
| -18% | -$67.8K | ﹤0.01% | 2857 |
|
|
2024
Q1 | $359K | Buy |
9,154
+5,801
| +173% | +$143K | ﹤0.01% | 2830 |
|
|
2023
Q4 | $20.3K | Hold |
3,353
| – | – | ﹤0.01% | 3941 |
|
|
2023
Q3 | $22.6K | Hold |
3,353
| – | – | ﹤0.01% | 3747 |
|
|
2023
Q2 | $26.3K | Sell |
3,353
-12
| -0.4% | -$108 | ﹤0.01% | 3723 |
|
|
2023
Q1 | $24.5K | Sell |
3,365
-7,748
| -70% | -$33.9K | ﹤0.01% | 3761 |
|
|
2022
Q4 | $36.8K | Sell |
11,113
-1,707
| -13% | -$6.57K | ﹤0.01% | 3545 |
|
|
2022
Q3 | $63K | Hold |
12,820
| – | – | ﹤0.01% | 3407 |
|
|
2022
Q2 | $97K | Hold |
12,820
| – | – | ﹤0.01% | 3337 |
|
|
2022
Q1 | $204K | Buy |
+12,820
| New | +$170K | ﹤0.01% | 3252 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4401 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4423 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4320 |
|
|
2020
Q4 | – | Sell |
-49,329
| Closed | -$2.66M | – | 3872 |
|
|
2020
Q3 | $2.66M | Sell |
49,329
-33
| -0.1% | -$5.98K | ﹤0.01% | 2236 |
|
|
2020
Q2 | $12.4M | Buy |
49,362
+33
| +0.1% | +$6.67K | ﹤0.01% | 1735 |
|
|
2020
Q1 | $7.75M | Buy |
49,329
+17,567
| +55% | +$2.97M | ﹤0.01% | 1778 |
|
|
2019
Q4 | $5.2M | Hold |
31,762
| – | – | ﹤0.01% | 2039 |
|
|
2019
Q3 | $4.64M | Hold |
31,762
| – | – | ﹤0.01% | 2082 |
|
|
2019
Q2 | $6.6M | Sell |
31,762
-8,390
| -21% | -$1.8M | ﹤0.01% | 2012 |
|
|
2019
Q1 | $8.37M | Sell |
40,152
-7,000
| -15% | -$1.54M | ﹤0.01% | 1921 |
|
|
2018
Q4 | $8.26M | Sell |
47,152
-27,037
| -36% | -$5.4M | ﹤0.01% | 1865 |
|
|
2018
Q3 | $16.8M | Sell |
74,189
-72,051
| -49% | -$11.6M | ﹤0.01% | 1751 |
|
|
2018
Q2 | $22.2M | Hold |
146,240
| – | – | ﹤0.01% | 1676 |
|
|
2018
Q1 | $26.8M | Buy |
146,240
+76,323
| +109% | +$17.1M | ﹤0.01% | 1592 |
|
|
2017
Q4 | $14.9M | Buy |
69,917
+44,997
| +181% | +$9.63M | ﹤0.01% | 1825 |
|
|
2017
Q3 | $5.34M | Sell |
24,920
-5,670
| -19% | -$1.11M | ﹤0.01% | 2139 |
|
|
2017
Q2 | $5.78M | Sell |
30,590
-953
| -3% | -$187K | ﹤0.01% | 2129 |
|
|
2017
Q1 | $7.81M | Sell |
31,543
-5,267
| -14% | -$1.29M | ﹤0.01% | 2048 |
|
|
2016
Q4 | $9.33M | Buy |
+36,810
| New | +$8.44M | ﹤0.01% | 1998 |
|
Other funds holding CRBP
CAM
O
VCM
PM
DP
SCM
AC
Fidelity Investments's CRBP Position: Q1 2026 in Review
Fidelity Investments reduced its Corbus Pharmaceuticals (CRBP) stake by 39% in Q1 2026, selling an estimated $3.71K and leaving 688 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4863.
Fidelity Investments first reported a position in CRBP in Q4 2016 and has held it in 33 quarters since. The position peaked at $26.8M in Q1 2018. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.
- Fidelity Investments held 688 shares of Corbus Pharmaceuticals worth $6.46K as of Q1 2026.
- Fidelity Investments sold 441 Corbus Pharmaceuticals shares in Q1 2026, an estimated $3.71K.
- Corbus Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4863 holding.
- Fidelity Investments first reported a position in Corbus Pharmaceuticals in Q4 2016 and has held it in 33 quarters since.
- Fidelity Investments's Corbus Pharmaceuticals position peaked at $26.8M in Q1 2018.
- 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.